10.1002/cmdc.201900641
ChemMedChem
FULL PAPER
= 5.6 Hz, 2H, NHCH2CH2), 4.39 (t, J = 5.2 Hz, 2H, NHCH2CH2O), methylbenzylamine (0.39 mL, 3 mmol). The mixture was
6.09 (br t, J = 5.2 Hz, 1H, NHCH2CH2O), 6.42 (d, J = 15.6 Hz, 1H, stirred at 70°C during 24h. After cooling to room temperature,
CHCHCOO), 6.47 (d, J = 15.6 Hz, 1H, CHCHCONH), 7.29-7.43 (m, the crude was solved in ethyl acetate (50 mL) and filtered to
6H, ArH), 7.49-7.54 (m, 4H, ArH), 7.65 (d, J = 15.6 Hz, 1H, recover the ecocatalyst. The filtrate was concentrated under
CHCHCOO), 7.73 (d, J = 15.6 Hz, 1H, CHCHCONH).13C NMR (100 vacuum and the resulting crude was purified by flash
MHz, CDCl3) δ (ppm): 39.4 (CH2), 63.6 (CH2), 117.5 (CH), 120.4 chromatography (EtOAc:n-heptane, 50:50 to 100:0) to provide
(CH), 128.0 (CHx2), 128.3 (CHx2), 129.0 (CHx2), 129.1 (CHx2),
129.9 (CH), 130.7 (CH), 134.3 (C), 134.9 (C), 141.6 (CH), 145.8
pure (2E)-3-Phenyl-N-[(1R)-1-phenylethyl]-2-propenamide (6)
in 40% yield; white solid; mp 139-141°C (CH2Cl2); Rf = 0.57
(CH), 166.1 (C), 167.3 (C). Anal. Calcd. For C20H19NO3: C, 74.75; (EtOAc:n-Hept; 5:5); IR ν (cm-1): 3306, 1652, 1620, 1541, 1224.
H, 5.96; N, 4.36. Found: C, 74.58; H, 6.08; N, 4.54%.
N-(2-((5-Oxopyrrolidin-2-yl)oxy)ethyl)cinnamamide (3). 5- CHCH3), 5.05 (quint, J = 7.8 Hz, 1H, CHCH3), 6.71 (d, J = 15.6 Hz,
1H NMR (400MHz, CDCl3) δ (ppm): 1.41 (d, J = 6.8 Hz, 3H,
Methoxypyrrolidine (0.45 g, 4 mmol) was added to a mixture
of idrocilamide ( ) (0.75 g, 4 mmol) and zinc (II) chloride (26.7
mg, 0.20 mmol) and the resulting mixture was stirred at 80°C
1H, CHCHCO), 7.21-7.26 (m, 1H, ArH), 7.33 (d, J = 3.1 Hz, 2H,
ArH), 7.37-7.43 (m, 5H, ArH), 7.42 (d, J = 15.6 Hz, 1H, CHCHCO),
7.55 (d, J = 7.1 Hz, 2H, ArH), 8.55 (d, J = 8.4 Hz, 1H, CONHCH).
1
during 24h. After cooling to room temperature, the crude was 13C NMR (100 MHz, DMSO-d6) δ (ppm): 22.5 (CH3), 48.0 (CH),
solved in CH2Cl2 (25mL) and washed with water (3x20mL). The 122.3 (CH), 126.0 (CHx2), 126.7 (CH), 127.5 (CHx2), 128.3
organic layers were concentrated under vacuum and the (CHx2), 128.9 (CHx2), 129.4 (CH), 134.9 (C), 128.8 (CH), 144.5
resulting crude was purified by flash chromatography (C), 164.0 (C). The physico-chemical properties correspond to
(EtOAc:n-heptane; 5:5 to 100:0) to provide pure N-(2-((5- those described in the literature.31
oxopyrrolidin-2-yl)oxy)ethyl)cinnamamide ( ) in 31% yield; N-(2,4-dichlorophenyl)-4-hydroxy-2-methyl-2H-1,2-
3
white solid; mp 113-116°C (EtOAc); Rf = 0.09 (EtOAc:n-Hept; benzothiazine-3-carboxamide 1,1-dioxide (9). A catalytic
9:1); IR ν (cm-1): 3304, 3184, 2902, 1702, 1662, 1630, 1531, amount of Ecocat2 (45 mg, 0.055 mmol) and 2,4-
1
1284, 1213. H NMR (400MHz, CDCl3) δ (ppm): 1.99-2.07 (m, dichloroaniline (178 mg, 1.1 mmol) were added to a solution
1H, CH2CH2CH), 2.18-2.31 (m, 2H, CH2CH2CH), 2.45-2.55 (m, of
methyl
2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-
1H, CH2CH2CH), 3.51-3.66 (m, 4H, NHCH2CH2O), 4.99 (d, J = 5.8 carboxylate 1,1-dioxide (300 mg, 1.1 mmol) in o-xylene (5 mL).
Hz, 1H, CONHCH), 6.50 (d, J = 15.4 Hz, 1H, CHCHCO), 6.72 (br The mixture was stirred at reflux for 47h. After cooling to room
t, J = 4.8 Hz, 1H, CHCONHCH2), 7.32-7.34 (m, 3H, ArH), 7.47- temperature, the crude was filtered to recover the
7.50 (m, 2H, ArH), 7.63 (d, J = 15.4 Hz, 1H, CHCHCO), 8.06 (br ecocatalyst. The filtrate was concentrated under vacuum and
s, 1H, CONHCHCO). 13C NMR (100 MHz, CDCl3) δ (ppm): 28.0 the resulting crude was purified by flash chromatography
(CH2), 28.5 (CH2), 39.6 (CH2), 66.0 (CH2), 86.5 (CH), 120.1 (CH), (CH2Cl2:MeOH, 100:0 to 90:10) to provide pure N-(2,4-
127.9 (CHx2), 128.9 (CHx2), 129.8 (CH), 134.9 (C), 141.1 (CH), dichlorophenyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-
166.4 (C), 179.5 (C). Anal. Calcd. For C15H18N2O3: C, 65.68; H, carboxamide 1,1-dioxide (9) in 27% yield; orange solid; mp
6.61; N, 10.21. Found: C, 65.73; H, 6.70; N, 10.90%.
232-234°C (CH2Cl2); Rf = 0.53 (EtOAc:n-Hept; 65:35); IR ν (cm-
1
N-Propyl-3-phenyl-2-propenamide (4). A catalytic amount 1): 3365, 1633, 1580, 1520, 1344, 1178. H NMR (400MHz,
of Ecocat2 (252 mg, 0.3 mmol) was added to a mixture of CDCl3) δ (ppm): 2.92 (s, 3H, NCH3), 3.42 (br s, 1H, OH), 7.51 (dd,
methyl cinnamate (1.0 g, 6 mmol) and propylamine (0.36 g, 6
mmol). The mixture was stirred at 70°C during 24h. After
cooling to room temperature, the crude was solved in ethyl
acetate (50 mL) and filtered to recover the ecocatalyst. The
filtrate was concentrated under vacuum and the resulting
J = 8.4, 2.2 Hz, 1H, ArH), 7.65 (d, J = 8.6 Hz, 1H, ArH), 7.78 (d, J
= 2.3 Hz, 1H, ArH), 7.87-7.95 (m, 3H, ArH), 8.04 (d, J = 6.5 Hz,
1H, ArH), 10.41 (br s, 1H, NHAr). 13C NMR (100 MHz, DMSO-d6)
δ (ppm): 40.2 (CH3), 111.4 (CH), 124.2 (CH), 126.3 (CH), 127.8
(CH), 127.8 (C), 129.1 (CH), 129.9 (C), 130.9 (C), 131.8 (C),
crude was purified by flash chromatography (EtOAc:n- 132.7 (C), 133.2 (CH), 133.6 (CH), 134.2 (C), 157.2 (C), 167.3
heptane, 5:5 to 100:0) to provide pure N-propyl-3-phenyl-2- (C).
propenamide (4) in 48% yield; brown solid; mp 75-78°C
(EtOAc); Rf = 0.61 (EtOAc:n-Hept; 6:4); IR ν (cm-1): 3262, 2968, Cell lines and yeast culture.
2361, 1652, 1610, 1548, 1341, 1221. 1H NMR (400MHz, CDCl3) The human monocytic THP-1 cells were incubated in RPMI
δ (ppm): 0.96 (t, J = 7.2 Hz, 3H, CH2CH2CH3), 1.60 (sext, J = 6.8 1640 medium (Gibco by LifeTechnologies™, France)
Hz, 2H, CH2CH2CH3), 3.36 (q, J = 7.2 Hz, 2H, CH2CH2CH3), 5.81 supplemented with 10% fetal bovine serum (FBS; Gibco,
(br s, 1H, CONHCH2), 6.41 (d, J = 15.6 Hz, 1H, ArCHCHCO), 7.34- France), 50 IU/mL penicillin, and 50 IU/mL streptomycin. THP-
7.35 (m, 3H, ArH), 7.48-7.50 (m, 2H, ArH), 7.62 (d, J = 15.6 Hz, 1 cells were differentiated into macrophages in the presence
1H, ArCHCHCO). 13C NMR (100 MHz, CDCl3) δ (ppm): 11.6 of phorbol-12-myristate 13-acetate (PMA, 25 nmol/L, Sigma-
(CH3), 23.1 (CH2), 41.6 (CH2), 121.0 (CH), 127.9 (CHx2), 128.9 Aldrich, France) at 37°C and 5% CO2. Caco-2 cells were grown
(CHx2), 129.7 (CH), 135.0 (C), 140.9 (CH), 166.0 (C). The
physico-chemical properties correspond to those described in
the literature.30
in Dulbecco's modified Eagle medium (DMEM) (Sigma-Aldrich,
France), supplemented with 20% FBS, 50 IU/mL penicillin and
50 IU/mL streptomycin at 37 °C and 5% CO2. C. albicans strain
(2E)-3-Phenyl-N-[(1R)-1-phenylethyl]-2-propenamide (6). A SC5314 was used in this study and maintained at 4ꢀ°C in yeast
catalytic amount of Ecocat2 (126 mg, 0.15 mmol) was added peptone dextrose broth (YPD; 1% yeast extract, 2% peptone,
to a mixture of methyl cinnamate (0.5 g, 3 mmol) and (R)-(+)- 2% dextrose). To prepare the yeast suspension, C. albicans
8
This article is protected by copyright. All rights reserved.